BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21107604)

  • 1. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
    Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
    Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
    Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
    J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
    Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
    J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Profile of Hyper-IgE Syndrome in India.
    Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
    Front Immunol; 2021; 12():626593. PubMed ID: 33717144
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
    Xie L; Hu X; Li Y; Zhang W; Chen L
    Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
    Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
    Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Infections and Surgical Complications in a Young Girl with Signal Transducer and Activator of Transcription 3 Loss-of-Function Mutation Hyperimmunoglobulin E Syndrome: A Case Report.
    Toribio-Dionicio C; Cubas-Guzmán D; Guerra-Canchari P; García-Sánchez V; Córdova-Calderón W
    Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):33-37. PubMed ID: 33734873
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology.
    Sundin M; Tesi B; Sund Böhme M; Bryceson YT; Pütsep K; Chiang SC; Thunberg S; Winiarski J; Wikström AC
    J Clin Immunol; 2014 May; 34(4):469-77. PubMed ID: 24627079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
    Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
    Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
    Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
    J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Park B; Liu GY
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
    Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
    J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.
    Saikia B; Suri D; Goel S; Rawat A; Minz RW; Gupta A; Sharma S; Ohara O; Imai K; Nonoyama S; Sehgal S; Singh S
    Asian Pac J Allergy Immunol; 2014 Dec; 32(4):321-7. PubMed ID: 25543043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
    Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
    Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
    Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
    Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
    Paulson ML; Freeman AF; Holland SM
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
    Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs.
    Yoshida Y; Nagamori T; Takahashi H; Ishibazawa E; Shimada S; Kawai T; Azuma H
    Pediatr Int; 2021 May; 63(5):510-515. PubMed ID: 32920916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
    Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
    Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
    Freeman AF; Holland SM
    Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.